We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
National Diabetes Audit Report 1- Findings and Recommendations 2016-17Audit
- Publication Date:
- 14 Mar 2018
- Geographic Coverage:
- Wales, England
- Geographical Granularity:
- Hospital Trusts, Local Authorities, Clinical Commissioning Groups, GP practices
- Date Range:
- 01 Jan 2016 to 31 Mar 2017
The National Diabetes Audit (NDA) is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP) which is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England. The NDA is managed by NHS Digital in partnership with Diabetes UK.
The NDA measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales. The NDA collects and analyses data for use by a range of stakeholders to drive changes and improvements in the quality of services and health outcomes for people with diabetes.
This report details the findings for the 2016-17 audit. The audit collected data during the Summer of 2017, for the period 1 January 2016 to 31 March 2017 and contains the full key findings, recommendations, results of analysis for multiple readings, and information for learning disability and severe mental illness.